UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue Sarcomas

International journal of molecular sciences, 2024-03, Vol.25 (6), p.3351

2024

Volltextzugriff (PDF)

Polytypic T-cell prolymphocytic leukemia

Blood, 2021-04, Vol.137 (15), p.2125-2125

2021

Volltextzugriff (PDF)

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

The Journal of immunology (1950), 2008-01, Vol.180 (1), p.163-170

2008

Volltextzugriff (PDF)

Murine natural killer cell licensing and regulation by T regulatory cells in viral responses

Proceedings of the National Academy of Sciences - PNAS, 2013-04, Vol.110 (18), p.7401-7406

2013

Volltextzugriff (PDF)

Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC

Blood, 2011-06, Vol.117 (26), p.7032-7041

2011

Volltextzugriff (PDF)

Advantages and clinical applications of natural killer cells in cancer immunotherapy

Cancer Immunology, Immunotherapy, 2014-01, Vol.63 (1), p.21-28

2014

Volltextzugriff (PDF)

NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

The Journal of immunology (1950), 2015-10, Vol.195 (8), p.4010-4019

2015

Volltextzugriff (PDF)

Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer

Clinical chemistry and laboratory medicine, 2022-06, Vol.60 (7), p.e159

2022

Volltextzugriff (PDF)

Treatment of chronic graft-versus-host disease with bortezomib

Blood, 2014-09, Vol.124 (10), p.1677-1688

2014

Volltextzugriff (PDF)

Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity

Immunity (Cambridge, Mass.), 2015-08, Vol.43 (2), p.240-250

2015

Volltextzugriff (PDF)

Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells

Oncoimmunology, 2015-09, Vol.4 (9), p.e1036212-e1036212

2015

Volltextzugriff (PDF)

Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid

Diagnostic cytopathology, 2018-07, Vol.46 (7), p.632-635

2018

Volltextzugriff (PDF)

Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing

Blood, 2012-02, Vol.119 (6), p.1590-1598

2012

Volltextzugriff (PDF)

Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment

International review of cell and molecular biology, 2022, Vol.370, p.65-122

2022

Volltextzugriff (PDF)

Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy

Blood, 2012-03, Vol.119 (13), p.3073-3083

2012

Volltextzugriff (PDF)

Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells

Cancers, 2019-01, Vol.11 (1), p.85

2019

Volltextzugriff (PDF)

The authors' reply

Transplantation, 2014-09, Vol.98 (5), p.e39

2014

Volltextzugriff (PDF)

Natural killer cell subsets differentially reject embryonic stem cells based on licensing

Transplantation, 2014-05, Vol.97 (10), p.992

2014

Volltextzugriff (PDF)

Abstract 1929: Tyrosine kinase inhibition with sorafenib but not pazopanib enriches for sarcoma cancer stem cells in diverse models of soft tissue sarcoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1929-1929

2014

Volltextzugriff (PDF)

Abstract 4894: Sorafenib enriches for sarcoma cancer stem cells in vitro

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4894-4894

2013

Volltextzugriff (PDF)

Intracranial administration of human activated NK cells in a xenogeneic model of orthotopic glioblastoma (169.18)

The Journal of immunology (1950), 2011-04, Vol.186 (1_Supplement), p.169-169.18

2011

Volltextzugriff (PDF)

Human and mouse natural killer cell cytotoxicity towards embryonic stem cells (169.41)

The Journal of immunology (1950), 2011-04, Vol.186 (1_Supplement), p.169-169.41

2011

Volltextzugriff (PDF)

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma

BMC cancer, 2014-10, Vol.14 (1), p.756-756, Article 756

2014

Volltextzugriff (PDF)

Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance

The Journal of immunology (1950), 2013-07, Vol.191 (2), p.688-698

2013

Volltextzugriff (PDF)

Immune targeting of cancer stem cells in gastrointestinal oncology

Journal of gastrointestinal oncology, 2016-04, Vol.7 (Suppl 1), p.S1-S10

2016

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(70)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(36)
Humans
(19)
Animals
(16)
Female
(16)
Mice
(14)
Immunology
(13)
Technology
(13)
Materials Science
(11)
Physical Sciences
(11)
Killer Cells, Natural - Immunology
(9)
Mice, Inbred C57bl
(9)
Hematology
(7)
Immunotherapy
(7)
Materials Science, Multidisciplinary
(7)
Physics
(7)
Cancer
(6)
Computer Science
(6)
Male
(6)
Oncology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue Sarcomas

Polytypic T-cell prolymphocytic leukemia

Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition

Murine natural killer cell licensing and regulation by T regulatory cells in viral responses

Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC

Advantages and clinical applications of natural killer cells in cancer immunotherapy

NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype

Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer

Treatment of chronic graft-versus-host disease with bortezomib

Out-of-Sequence Signal 3 Paralyzes Primary CD4+ T-Cell-Dependent Immunity

Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells

Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid

Mouse NK cell–mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing

Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment

Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy

Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells

The authors' reply

Natural killer cell subsets differentially reject embryonic stem cells based on licensing

Abstract 1929: Tyrosine kinase inhibition with sorafenib but not pazopanib enriches for sarcoma cancer stem cells in diverse models of soft tissue sarcoma

Abstract 4894: Sorafenib enriches for sarcoma cancer stem cells in vitro

Intracranial administration of human activated NK cells in a xenogeneic model of orthotopic glioblastoma (169.18)

Human and mouse natural killer cell cytotoxicity towards embryonic stem cells (169.41)

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma

Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance

Immune targeting of cancer stem cells in gastrointestinal oncology

Suchergebnisse filtern